P2RX7 Enhances Tumor Control by CD8+ T Cells in Adoptive Cell Therapy.

Overview of attention for article published in Cancer Immunology Research, May 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

twitter: 15 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 13 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 25 X posts from 15 X users, with an upper bound of 13,927 followers.

RT @UMNMSTP: Kelsey received an NIH F30 award to help support her research and is a past MSTP representative to the medical school student…

03 Mar 2023

Reply Repost Favourite

Kelsey received an NIH F30 award to help support her research and is a past MSTP representative to the medical school student council. Check out her most recent first-author publication below! (2/2) https://t.co/IXSeanLGWL

03 Mar 2023

Reply Repost Favourite

The authors of "P2RX7 enhances tumor control by CD8+ T cells in ad…" (https://t.co/xHoIfrNjAm) included RRIDs in their paper! RRIDs like this improve reproducibility in scientific research. #ReproducibleResearch #reproducibility

10 Jan 2023

Reply Repost Favourite

RT @CIR_AACR: Learn how the purinergic receptor P2RX7 affects mitochondrial function and survival of CD8s in this study by Kelsey M. Wanhai…

23 Sep 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 21 additional X posts.